Wells Fargo’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-379
| Closed | -$152 | – | 6708 |
|
|
2024
Q1 | $152 | Buy |
379
+6
| +2% | +$2 | ﹤0.01% | 6171 |
|
|
2023
Q4 | $104 | Buy |
373
+74
| +25% | +$21 | ﹤0.01% | 6315 |
|
|
2023
Q3 | $107 | Sell |
299
-57
| -16% | -$20 | ﹤0.01% | 6380 |
|
|
2023
Q2 | $111 | Buy |
356
+15
| +4% | +$5 | ﹤0.01% | 6536 |
|
|
2023
Q1 | $116 | Buy |
341
+5
| +1% | +$2 | ﹤0.01% | 6582 |
|
|
2022
Q4 | $107 | Buy |
336
+12
| +4% | +$4 | ﹤0.01% | 6448 |
|
|
2022
Q3 | $0 | Buy |
324
+27
| +9% | – | ﹤0.01% | 6638 |
|
|
2022
Q2 | $0 | Buy |
297
+24
| +9% | – | ﹤0.01% | 6797 |
|
|
2022
Q1 | $0 | Buy |
273
+1
| +0.4% | – | ﹤0.01% | 6919 |
|
|
2021
Q4 | $0 | Buy |
272
+7
| +3% | – | ﹤0.01% | 6913 |
|
|
2021
Q3 | $0 | Sell |
265
-3,971
| -94% | – | ﹤0.01% | 6854 |
|
|
2021
Q2 | $7K | Buy |
4,236
+3,998
| +1,680% | +$6.61K | ﹤0.01% | 5904 |
|
|
2021
Q1 | $0 | Buy |
238
+20
| +9% | – | ﹤0.01% | 6696 |
|
|
2020
Q4 | $0 | Sell |
218
-987
| -82% | – | ﹤0.01% | 6343 |
|
|
2020
Q3 | $1K | Buy |
1,205
+976
| +426% | +$810 | ﹤0.01% | 5845 |
|
|
2020
Q2 | $0 | Buy |
229
+2
| +0.9% | – | ﹤0.01% | 6108 |
|
|
2020
Q1 | $0 | Buy |
+227
| New | – | ﹤0.01% | 6071 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | – | – | 6022 |
|
|
2019
Q1 | $0 | Buy |
+200
| New | – | ﹤0.01% | 5945 |
|
|
2014
Q3 | – | Sell |
-293,442
| Closed | -$417K | – | 5986 |
|
|
2014
Q2 | $417K | Hold |
293,442
| – | – | ﹤0.01% | 3942 |
|
|
2014
Q1 | $229K | Hold |
293,442
| – | – | ﹤0.01% | 4202 |
|
|
2013
Q4 | $305K | Hold |
293,442
| – | – | ﹤0.01% | 4000 |
|
|
2013
Q3 | $308K | Hold |
293,442
| – | – | ﹤0.01% | 3958 |
|
|
2013
Q2 | $470K | Buy |
+293,442
| New | +$470K | ﹤0.01% | 3695 |
|